BRIEF-Cmg Announces The Acquisition Of Sharp Reflections GmbH-March 2024-www.financetom.com

BRIEF-Cmg Announces The Acquisition Of Sharp Reflections GmbH

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Cmg Announces The Acquisition Of Sharp Reflections GmbH

Nov 12, 2024 9:55 PM

Nov 12 (Reuters) - Computer Modelling Group Ltd ( CMDXF )

* CMG ANNOUNCES THE ACQUISITION OF SHARP REFLECTIONS GMBH

* COMPUTER MODELLING GROUP LTD ( CMDXF ) - PAYS €25 MILLION ($37

MILLION)

FOR SHARP REFLECTIONS

* COMPUTER MODELLING GROUP LTD ( CMDXF ) - BILL SHEA TO REMAIN AS CEO

SHARP REFLECTIONS

Source text:

Further company coverage:

Previous page： Boeing's Starliner capsule is launched from Florida on first crewed space flight Next page： Atea Pharmaceuticals Shares Promising Data From Therapy Study For Hepatitis C Virus

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Boeing's Starliner capsule is launched from Florida on first crewed space flight

Jun 5, 2024

WASHINGTON, June 5 (Reuters) - Boeing's ( BA ) new Starliner astronaut capsule was launched from Florida on Wednesday in a much-delayed first test flight carrying a crew, a milestone in the aerospace giant's ambitions to step up its competition with Elon Musk's SpaceX. The CST-100 Starliner, with two astronauts aboard, lifted off from the Cape Canaveral Space Force Station...

Atea Pharmaceuticals Shares Promising Data From Therapy Study For Hepatitis C Virus

Jun 5, 2024

Atea Pharmaceuticals Inc ( AVIR ) announced Wednesday new data from the lead-in cohort (n=60) of the company’s ongoing Phase 2 combination study of bemnifosbuvir for hepatitis C virus (HCV). With an eight-week treatment duration in 60 patients, the Phase 2 data from the lead-in cohort of non-cirrhotic patients showed a 97% sustained virologic response rate at 12 weeks post-treatment...

--Boeing's Starliner Lifts Off on First Crewed Mission

Jun 5, 2024

10:56 AM EDT, 06/05/2024 (MT Newswires) -- Price: 189.02, Change: +0.40, Percent Change: +0.21 ...

What's Going On With MindMed And Psychedelic Stocks?

Jun 5, 2024

Mind Medicine (MindMed) Inc. ( MNMD ) shares are trading lower Wednesday after a Food and Drug Administration (FDA) panel rejected the approval of MDMA therapy for people with post-traumatic stress disorder (PTSD). The Details: MindMed and other psychedelic stocks, including ATAI Life Sciences N.V ( ATAI ) and COMPASS Pathways Plc ( CMPS ) , are down after an...